- Home
- INHD vs BIVI Comparison
INHD vs BIVI Comparison
Compare INHD & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INHD
- BIVI
- Stock Information
- Founded
- INHD 2019
- BIVI 2013
- Country
- INHD United States
- BIVI United States
- Employees
- INHD N/A
- BIVI N/A
- Industry
- INHD
- BIVI Biotechnology: Pharmaceutical Preparations
- Sector
- INHD
- BIVI Health Care
- Exchange
- INHD Nasdaq
- BIVI Nasdaq
- Market Cap
- INHD 19.8M
- BIVI 18.8M
- IPO Year
- INHD 2023
- BIVI N/A
- Fundamental
- Price
- INHD $4.86
- BIVI $0.95
- Analyst Decision
- INHD
- BIVI Strong Buy
- Analyst Count
- INHD 0
- BIVI 1
- Target Price
- INHD N/A
- BIVI $30.00
- AVG Volume (30 Days)
- INHD 7.2K
- BIVI 230.4K
- Earning Date
- INHD 05-12-2025
- BIVI 05-13-2025
- Dividend Yield
- INHD N/A
- BIVI N/A
- EPS Growth
- INHD N/A
- BIVI N/A
- EPS
- INHD N/A
- BIVI N/A
- Revenue
- INHD $916,878.00
- BIVI N/A
- Revenue This Year
- INHD N/A
- BIVI N/A
- Revenue Next Year
- INHD N/A
- BIVI N/A
- P/E Ratio
- INHD N/A
- BIVI N/A
- Revenue Growth
- INHD 39.48
- BIVI N/A
- 52 Week Low
- INHD $3.00
- BIVI $0.80
- 52 Week High
- INHD $9.10
- BIVI $7.50
- Technical
- Relative Strength Index (RSI)
- INHD 59.09
- BIVI 37.09
- Support Level
- INHD $4.30
- BIVI $0.99
- Resistance Level
- INHD $4.81
- BIVI $1.10
- Average True Range (ATR)
- INHD 0.23
- BIVI 0.10
- MACD
- INHD 0.05
- BIVI 0.01
- Stochastic Oscillator
- INHD 83.42
- BIVI 34.07
About INHD Inno Holdings Inc.
Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.